WMSA
AMAG

Weiss Multi-Strategy Advisers’s AMAG Pharmaceuticals AMAG Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-20,720
Closed -$401K – 1004
2014
Q1 		$401K Buy
+20,720
New +$440K 0.01% 762

Other funds holding AMAG

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Weiss Multi-Strategy Advisers's AMAG Position: Q2 2014 in Review

Weiss Multi-Strategy Advisers sold out of AMAG Pharmaceuticals (AMAG) in Q2 2014, closing a stake of 20,720 shares — an estimated $401K sold.

Weiss Multi-Strategy Advisers first reported a position in AMAG in Q1 2014 and held it in 1 quarter. The position peaked at $401K in Q1 2014. 100 funds tracked by Wall St. Rank hold AMAG as of Q2 2014.

  • Weiss Multi-Strategy Advisers reported no remaining AMAG Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 20,720 AMAG Pharmaceuticals shares in Q2 2014, an estimated $401K.
  • Weiss Multi-Strategy Advisers first reported a position in AMAG Pharmaceuticals in Q1 2014 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's AMAG Pharmaceuticals position peaked at $401K in Q1 2014.
  • 100 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2014, filed 14 Aug 2014.